Recursion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discov…

Biotechnology
US, Salt Lake City [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Recursion Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Recursion Pharmaceuticals, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Recursion Pharmaceuticals, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of RXRX's Analysis
CIK: 1601830 CUSIP: 75629V104 ISIN: US75629V1044 LEI: - UEI: -
Secondary Listings
RXRX has no secondary listings inside our databases.